Meta-analysis on resected pancreatic cancer: a comparison between adjuvant treatments and gemcitabine alone

被引:0
作者
Hua Chen
Ruizhi He
Xiuhui Shi
Min Zhou
Chunle Zhao
Hang Zhang
Renyi Qin
机构
[1] Huazhong University of Science and Technology,Department of Biliary
来源
BMC Cancer | / 18卷
关键词
Pancreatic cancer; Gemcitabine; Chemotherapy; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 285 条
[1]  
Siegel RL(2018)Cancer statistics, 2018 CA Cancer J Clin 68 7-30
[2]  
Miller KD(2003)Treatment of pancreatic cancer: challenge of the facts World J Surg 27 1075-1084
[3]  
Jemal A(2006)Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States) Cancer Causes Control 17 403-409
[4]  
Beger HG(1999)Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1-7
[5]  
Rau B(2007)Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA 297 267-277
[6]  
Gansauge F(2009)Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma Eur J Surg Oncol 35 600-604
[7]  
Poch B(1993)An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging Cancer 72 2118-2123
[8]  
Link KH(2004)Current standards of surgery for pancreatic cancer Br J Surg 91 1410-1427
[9]  
Cress RD(2007)Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO, ARO, and CAO) BMC Cancer 7 41-903
[10]  
Yin D(1985)Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 899-1026